The potential of interleukin-37 as an effective therapeutic agent in asthma.

about

The potential of interleukin-37 as an effective therapeutic agent in asthma.

Item

http://www.wikidata.org/entity/Q47120024

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The potential of interleukin-37 as an effective therapeutic agent in asthma.

@en

The potential of interleukin-37 as an effective therapeutic agent in asthma.

@nl

type

Item

label

The potential of interleukin-37 as an effective therapeutic agent in asthma.

@en

The potential of interleukin-37 as an effective therapeutic agent in asthma.

@nl

prefLabel

The potential of interleukin-37 as an effective therapeutic agent in asthma.

@en

The potential of interleukin-37 as an effective therapeutic agent in asthma.

@nl

P1476

The potential of interleukin-37 as an effective therapeutic agent in asthma

@en

P2093

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Lina Zhang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Four new members expand the interleukin-1 superfamily

Identification and gene organization of three novel members of the IL-1 family on human chromosome 2

IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp

Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production

Genomic organization of the interleukin-1 locus

Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity

IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction

IL-37 is a fundamental inhibitor of innate immunity

Epithelial expression of interleukin-37b in inflammatory bowel disease

Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis

P2888

s12931-017-0675-x

P304

192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12931-017-0675-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peng Gao

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092690004

http://www.w3.org/2001/XMLSchema#string

P698

29137646

http://www.w3.org/2001/XMLSchema#string

P921

peptide

asthma

P932

5686801

http://www.w3.org/2001/XMLSchema#string